SCHEMBL3258690

SCHEMBL3258690

O=C(ON=NC(=O)c1ccccc1Oc1ccccc1)ON=NC(=O)c1ccccc1Oc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.49
ALDH1A1 P00352 5/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
HSD17B10 Q99714 2/20 0.46
TSHR P16473 2/20 0.46
TP53 P04637 1/20 0.46
MAPK1 P28482 2/20 0.44
RAB9A P51151 1/20 0.43
L3MBTL1 Q9Y468 4/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HTT P42858 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
MAPK8 P45983 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3261986 0.81 HPGD (0.49) SMN1; SMN2ALDH1A1KMT2ALMNAMAPT
SCHEMBL3174780 0.80 HPGD (0.49) SMN1; SMN2ALDH1A1KMT2AMAPTHSD17B10
SCHEMBL10426368 0.79 CTNNB1 (0.56) CTNNB1SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL3259032 0.78 HTT (0.53) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL3259313 0.77 ELANE (0.37) CTNNB1SMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL3258435 0.77 HCRTR1 (0.51) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL3261086 0.77 IRAK4 (0.59) ALDH1A1KMT2ALMNAHSD17B10HTT
SCHEMBL3260590 0.77 LMNA (0.56) SMN1; SMN2ALDH1A1MEN1KMT2ALMNA
SCHEMBL3165770 0.76 USP2 (0.39) CTNNB1SMN1; SMN2ALDH1A1KMT2AMAPT
SCHEMBL3190739 0.76 IRAK4 (0.51) CTNNB1ALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8952189-B2 Process for preparing diaryl carbonates or alkyl aryl carbonates from dialkyl carbonates BAYER MATERIALSCIENCE AG (DE) 2015-02-10 US disclosed
US-20100261928-A1 PROCESS FOR PREPARING DIARYL CARBONATES OR ALKYL ARYL CARBONATES FROM DIALKYL CARBONATES BAYER MATERIALSCIENCE AG (DE) 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261928-A1 PROCESS FOR PREPARING DIARYL CARBONATES OR ALKYL ARYL CARBONATES FROM DIALKYL CARBONATES HDHD5, AHR, AGL CTNNB1 327/4885SMN1; SMN2 4772/4885ALDH1A1 3535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.